Literature DB >> 16966253

The relevance of information generated by in vitro experimental models to clinical doxorubicin cardiotoxicity.

Steven E Lipshultz1, Harvey Cohen, Steven D Colan, Eugene H Herman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16966253     DOI： 10.1080/10428190600800231

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  8 in total

1.  Anthracycline cardiotoxicity: the importance of horizontally integrating pre-clinical and clinical research.

Authors:  Steven E Lipshultz; Eugene H Herman
Journal:  Cardiovasc Res       Date:  2018-02-01       Impact factor: 10.787

2.  Letter by Lipshultz Regarding Article, "Anthracycline Cardiotoxicity: Worrisome Enough to Have You Quaking?"

Authors:  Steven E Lipshultz
Journal:  Circ Res       Date:  2018-03-30       Impact factor: 17.367

3.  Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection.

Authors:  Rosalinda Madonna; Christian Cadeddu; Martino Deidda; Donato Mele; Ines Monte; Giuseppina Novo; Pasquale Pagliaro; Alessia Pepe; Paolo Spallarossa; Carlo Gabriele Tocchetti; Concetta Zito; Giuseppe Mercuro
Journal:  Heart Fail Rev       Date:  2015-09       Impact factor: 4.214

4.  Creating a Biomarker Panel for Early Detection of Chemotherapy Related Cardiac Dysfunction in Breast Cancer Patients.

Authors:  Krithika Srikanthan; Rebecca Klug; Maria Tirona; Ellen Thompson; Haresh Visweshwar; Nitin Puri; Joseph Shapiro; Komal Sodhi
Journal:  J Clin Exp Cardiolog       Date:  2017-03-22

5.  Anthracycline cardiotoxicity: from bench to bedside.

Authors:  Luca Gianni; Eugene H Herman; Steven E Lipshultz; Giorgio Minotti; Narine Sarvazyan; Douglas B Sawyer
Journal:  J Clin Oncol       Date:  2008-08-01       Impact factor: 44.544

Review 6.  Iron chelators with topoisomerase-inhibitory activity and their anticancer applications.

Authors:  V Ashutosh Rao
Journal:  Antioxid Redox Signal       Date:  2012-10-26       Impact factor: 8.401

7.  Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab.

Authors:  Bonnie Ky; Mary Putt; Heloisa Sawaya; Benjamin French; James L Januzzi; Igal A Sebag; Juan Carlos Plana; Victor Cohen; Jose Banchs; Joseph R Carver; Susan E Wiegers; Randolph P Martin; Michael H Picard; Robert E Gerszten; Elkan F Halpern; Jonathan Passeri; Irene Kuter; Marielle Scherrer-Crosbie
Journal:  J Am Coll Cardiol       Date:  2013-11-27       Impact factor: 24.094

Review 8.  Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors.

Authors:  Neha Bansal; M Jacob Adams; Sarju Ganatra; Steven D Colan; Sanjeev Aggarwal; Rudolf Steiner; Shahnawaz Amdani; Emma R Lipshultz; Steven E Lipshultz
Journal:  Cardiooncology       Date:  2019-12-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.